Farms.com Home   News

Manitoba Harvest Makes Better Progress

Manitoba producers made better harvest progress this past week, with particularly large gains made in canola. 

The weekly provincial crop report on Tuesday pegged the overall harvest at 63% complete, up from 47% a week earlier but still about three weeks behind the five-year average of 86%. In the previous two weeks combined, the Manitoba harvest advanced by just a combined 15 points amid rain and high humidity levels. 

The canola harvest jumped to 58% complete from 30% a week earlier, the report said, with over 1.9 million acres now combined. Meanwhile, 85% of the spring wheat crop was in the bin, along with 96% of the barley, 82% of the oats, 99% of the peas and 3% of the flax. Soybeans were 11% harvested while the corn harvest is just now getting under way. 

Some wheat crops harvested after recent rains have been downgraded to No. 3 CWRS as a result of mildew and sprouting, while most remain a No. 2 CWRS. Swathing yet-unharvested crops is much more common across the province this year to reduce green straw problems and increase combine speed and efficiency, the report said. 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.